Clinical Trials on 早期乳腺癌 in United Kingdom
总计7599个结果
-
Michael SimonNational Cancer Institute (NCI)完全的浸润性乳腺癌 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7美国
-
National Cancer Institute (NCI)完全的乳腺癌 | I期乳腺癌 | II期乳腺癌 | III期乳腺癌美国
-
Northwestern UniversityBreast Cancer Research Foundation; Repros Therapeutics Inc.未知
-
George W. Sledge Jr.National Cancer Institute (NCI)完全的IV 期乳腺癌 | 复发性乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | HER2阳性乳腺癌 | III期乳腺癌美国
-
National Cancer Institute (NCI)终止IIIA期乳腺癌 | IIIB期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性 | 三阴性乳腺癌美国
-
Indiana University School of MedicineBreast Cancer Research Foundation完全的Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer (EPC)乳腺癌第四期 | 乳腺癌一期 | 乳腺癌二期美国
-
Craig A. Bunnell, MD, MPHMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center 和其他合作者完全的
-
Jonsson Comprehensive Cancer Center完全的癌症幸存者 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | IIIA 期乳腺癌 AJCC v7 | 0 期乳腺癌 AJCC v6 和 v7美国
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Susan G. Komen Breast Cancer Foundation完全的II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 三阴性乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌美国
-
University of WashingtonNational Cancer Institute (NCI)完全的炎性乳腺癌 | 男性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌美国
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); University of Pittsburgh; Case Western Reserve University招聘中
-
Mayo ClinicNational Cancer Institute (NCI)完全的转移性三阴性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 乳腺癌美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | HER2/Neu 阴性 | 晚期乳腺癌 | 转移性乳腺癌 | 种系 BRCA1 基因突变 | 种系 BRCA2 基因突变美国
-
University of California, San FranciscoPuma Biotechnology, Inc.完全的HER2阳性乳腺癌 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 乳腺癌美国
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人IV 期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 浸润性乳腺癌 | IIIC期乳腺癌 | HER2/Neu 阴性 | III期乳腺癌 | 绝经后 | 雌激素受体状态美国
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人炎性乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 三阴性乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性美国
-
University of WashingtonNational Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)完全的IIIA期乳腺癌 | IIIB期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌美国
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Hoffmann-La Roche; Brigham and Women's Hospital终止
-
Mayo ClinicNational Cancer Institute (NCI)完全的癌症幸存者 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | III 期结肠癌 AJCC v7 | IIIA 期结肠癌 AJCC v7 | IIIB 期结肠癌 AJCC v7 | IIIC 期结肠癌 AJCC v7 | I 期结肠癌 AJCC v6 和 v7 | II 期结肠癌 AJCC v7 | IIA 期结肠癌 AJCC... 及其他条件美国
-
University of California, San FranciscoAmgen主动,不招人解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 复发性乳腺癌 | 浸润性乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性美国
-
University of WashingtonNational Cancer Institute (NCI)终止
-
Ohio State University Comprehensive Cancer Center主动,不招人沮丧 | 复发性乳腺癌 | IIIA期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 癌症治疗的认知副作用美国
-
National Cancer Institute (NCI)终止复发性乳腺癌 | IIIA期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 男性乳腺癌美国
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)完全的神经毒性 | 周围神经病变 | 男性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌美国
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | HER2阳性乳腺癌美国
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的复发性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 IIB 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性 | 三阴性乳腺癌 | IIB 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB... 及其他条件美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中浸润性乳腺癌 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | IIIA 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7美国
-
National Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer Center招聘中解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后... 及其他条件美国
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后... 及其他条件美国
-
National Cancer Institute (NCI)终止复发性乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性美国
-
Stanford UniversityCalifornia Breast Cancer Research Program完全的沮丧 | 创伤后应激障碍 | IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌美国
-
University College, LondonNational Institute for Health Research, United Kingdom未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 乳腺癌美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 晚期恶性实体瘤 | 不可切除的恶性实体肿瘤 | 转移性恶性实体瘤 | 复发性乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性 | TP53 wt 等位基因美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 复发性乳腺癌 | HER2/Neu 阴性 | 三阴性乳腺癌 | 晚期乳腺癌 | 雄激素受体阳性 | 转移性乳腺癌 | PTEN阳性 | 难治性乳腺癌美国
-
Memorial Sloan Kettering Cancer Center主动,不招人
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)招聘中II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 乳腺癌美国
-
University of Utah主动,不招人0 期乳腺癌 | I期乳腺癌 | II期乳腺癌 | 浸润性乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 乳腺导管原位癌美国
-
Gary MorrowNational Cancer Institute (NCI); Stanford University完全的睡眠障碍 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌美国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Seagen Inc.招聘中解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后 IIB 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后... 及其他条件美国, 加拿大, 波多黎各
-
University of Maryland, BaltimoreSyndax Pharmaceuticals终止I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | 三阴性乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌美国